Percutaneous edge-to-edge repair in complex mitral regurgitation, is it really a contraindication?
DOI:
https://doi.org/10.37615/retic.v6n3a12Keywords:
mitral regurgitation, transcatheter edge to edge repair, acute heart failureAbstract
Transcatheter edge to edge repair (TEER) represents an effective alternative to valve repair surgery in patients with severe primary mitral regurgitation in whom surgical risk is unacceptable. Adequate prior echocardiographic study is essential for the success of the therapy. Different prognostic scores and criteria have been published to guide the patient selection. We report the case of a 77-year-old woman admitted to our hospital with acutely decompensated heart failure in whom a severe primary mitral regurgitation with a complex valvular anatomy was effectively treated by TEER.
Downloads
Metrics
References
Wang TK, Harmos S, Gamble GD, Ramanathan T, Ruygrok PN. Performance of contemporary surgical risk scores for mitral valve surgery. J Card Surg. 2017 Mar;32(3):172-176. doi: https://doi.org/10.1111/jocs.13107 DOI: https://doi.org/10.1111/jocs.13107
Raposeiras-Roubin S, Adamo M, Freixa X, Arzamendi D, Benito-González T, Montefusco A, et al. A Score to Assess Mortality After Percutaneous Mitral Valve Repair. J Am Coll Cardiol. 2022 Feb 15;79(6):562-573. doi: https://doi.org/10.1016/j.jacc.2021.11.041 DOI: https://doi.org/10.1016/j.jacc.2021.11.041
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e35-e71. doi: https://doi.org/10.1161/CIR.0000000000000932 DOI: https://doi.org/10.1161/CIR.0000000000000932
Hahn RT, Saric M, Faletra FF, Garg R, Gillam LD, Horton K, et al. Recommended Standards for the Performance of Transesophageal Echocardiographic Screening for Structural Heart Intervention: From the American Society of Echocardiography. J Am Soc Echocardiogr. 2022 Jan;35(1):1-76. doi: https://doi.org/10.1016/j.echo.2021.07.006 DOI: https://doi.org/10.1016/j.echo.2021.07.006
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. DOI: https://doi.org/10.1093/eurheartj/ehab626
Feb 12;43(7):561-632. doi: https://doi.org/10.1093/eurheartj/ehab395 DOI: https://doi.org/10.1093/eurheartj/ehab395
Boekstegers P, Hausleiter J, Baldus S, Von Bardeleben RS, Beucher H, Butter C, et al. Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol. 2014 Feb;103(2):85-96. doi: https://doi.org/10.1007/s00392-013-0614-x DOI: https://doi.org/10.1007/s00392-013-0614-x
Chhatriwalla AK, Vemulapalli S, Szerlip M, Kodali S, Hahn RT, Saxon JT, et al. Operator Experience and Outcomes of Transcatheter Mitral Valve Repair in the United States. J Am Coll Cardiol. 2019 Dec;74(24):2955-65. doi: https://doi.org/10.1016/j.jacc.2019.09.014 DOI: https://doi.org/10.1016/j.jacc.2019.09.014
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Javier Herrera Flores, Alberto Piserra López-Fernández De Heredia, Dolores Mesa Rubio , Manuel Pan Álvarez- Ossorio , Miguel Romero Moreno
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.
